Literature DB >> 15211130

Effects of head and extracranial injuries on serum protein S100B levels in trauma patients.

Olli Savola1, Juhani Pyhtinen, Tuomo K Leino, Simo Siitonen, Onni Niemelä, Matti Hillbom.   

Abstract

BACKGROUND: Serum protein S100B determinations have been recently suggested as markers of traumatic brain injury. However, little is known about the effects of extracranial injuries on S100B levels in trauma patients.
METHODS: We studied 224 patients with head trauma (54 of whom also had extracranial injuries), 155 patients with various types of extracranial injuries, and 8 healthy pilots exposed to high Gz forces. The head trauma patients had either no brain injury (n = 35), mild brain injury (n = 165), or moderate to severe brain injury (n = 24). The extracranial injuries were divided into small and large injuries. Serum protein S100B levels were determined from samples taken within 6 hours after the trauma event.
RESULTS: The head trauma patients had a significantly higher median S100B (0.17 microg/L) than the patients with extracranial injuries (0.07 microg/L) (p < 0.001). Serum S100B levels also correlated with the severity of brain injury (p < 0.001), the highest values occurring in the patients with moderate to severe brain injury (1.27 microg/L). However, large extracranial injuries also elevated S100B levels (0.35 microg/L), whereas small extracranial injuries in the absence of head trauma did not significantly affect S100B levels (0.07 microg/L). Above the cutoff level of 0.13 microg/L, there were 61% of the head trauma patients and 26% of those with extracranial injuries (Pearson chi test, p < 0.001). However, only 4% of the patients with purely extracranial injuries had a concentration of S100B above the cutoff level of 0.50 microg/L, whereas the head trauma patients with moderate to severe brain injury exceeded this cutoff in 67% of the cases. Exposure to high Gz forces did not influence serum S100B levels in healthy individuals.
CONCLUSION: We conclude that serum S100B is a sensitive marker of brain injury, which correlates with the severity of the injury. Large extracranial injuries also elevate S100B levels. However, S100B has a high negative predictive power, and the finding of a normal S100B value shortly after trauma should thus exclude significant brain injury with a high accuracy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15211130     DOI: 10.1097/01.ta.0000096644.08735.72

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  68 in total

Review 1.  Predictive biomarkers of recovery in traumatic brain injury.

Authors:  Sabrina Giacoppo; Placido Bramanti; Marina Barresi; Debora Celi; Valeria Foti Cuzzola; Eleonora Palella; Silvia Marino
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

2.  S100B protein may detect brain death development after severe traumatic brain injury.

Authors:  Juan J Egea-Guerrero; Francisco Murillo-Cabezas; Elena Gordillo-Escobar; Ana Rodríguez-Rodríguez; Judy Enamorado-Enamorado; Jaume Revuelto-Rey; María Pacheco-Sánchez; Antonio León-Justel; Jose M Domínguez-Roldán; Angel Vilches-Arenas
Journal:  J Neurotrauma       Date:  2013-08-28       Impact factor: 5.269

Review 3.  S100B as a marker for brain damage and blood-brain barrier disruption following exercise.

Authors:  Serene X T Koh; Jason K W Lee
Journal:  Sports Med       Date:  2014-03       Impact factor: 11.136

4.  Brain-Specific Serum Biomarkers Predict Neurological Morbidity in Diagnostically Diverse Pediatric Intensive Care Unit Patients.

Authors:  Alicia K Au; Michael J Bell; Ericka L Fink; Rajesh K Aneja; Patrick M Kochanek; Robert S B Clark
Journal:  Neurocrit Care       Date:  2018-02       Impact factor: 3.210

Review 5.  Systems biology approaches for discovering biomarkers for traumatic brain injury.

Authors:  Jacob D Feala; Mohamed Diwan M Abdulhameed; Chenggang Yu; Bhaskar Dutta; Xueping Yu; Kara Schmid; Jitendra Dave; Frank Tortella; Jaques Reifman
Journal:  J Neurotrauma       Date:  2013-07-01       Impact factor: 5.269

6.  Acupuncture as a multifunctional neuroprotective therapy ameliorates cognitive impairment in a rat model of vascular dementia: A quantitative iTRAQ proteomics study.

Authors:  Jing-Wen Yang; Xue-Rui Wang; Meng Zhang; Ling-Yong Xiao; Wen Zhu; Cai-Shuo Ji; Cun-Zhi Liu
Journal:  CNS Neurosci Ther       Date:  2018-10-02       Impact factor: 5.243

7.  Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest.

Authors:  Robert Siman; Victoria L Roberts; Elizabeth McNeil; Antony Dang; Joseph E Bavaria; Sindhu Ramchandren; Michael McGarvey
Journal:  Brain Res       Date:  2008-04-01       Impact factor: 3.252

8.  Overexpression of human S100B exacerbates brain damage and periinfarct gliosis after permanent focal ischemia.

Authors:  Takashi Mori; Jun Tan; Gary W Arendash; Naoki Koyama; Yoshiko Nojima; Terrence Town
Journal:  Stroke       Date:  2008-05-01       Impact factor: 7.914

9.  Assessing bicycle-related trauma using the biomarker S100B reveals a correlation with total injury severity.

Authors:  E P Thelin; E Zibung; L Riddez; C Nordenvall
Journal:  Eur J Trauma Emerg Surg       Date:  2015-10-21       Impact factor: 3.693

10.  The Passage of S100B from Brain to Blood Is Not Specifically Related to the Blood-Brain Barrier Integrity.

Authors:  Andrea Kleindienst; Christian Schmidt; Hans Parsch; Irene Emtmann; Yu Xu; Michael Buchfelder
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.